Chicago Equity Partners’s Zimmer Biomet ZBH Stock Holding History

Chicago Equity Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.1M	Sell	11,186 -6,458	-37%	-$847K	0.11%	263
2019 Q4	$2.56M	Sell	17,644 -5,165	-23%	-$713K	0.15%	205
2019 Q3	$3.04M	Buy	22,809 +7,277	+47%	+$940K	0.14%	210
2019 Q2	$1.78M	Buy	15,532 +1,303	+9%	+$153K	0.08%	358
2019 Q1	$1.76M	Buy	14,229 +8,693	+157%	+$988K	0.07%	373
2018 Q4	$557K	Buy	+5,536	New	+$623K	0.02%	616
2016 Q4	–	Sell	-2,101	Closed	-$265K	–	804
2016 Q3	$265K	Sell	2,101 -83	-4%	-$10.3K	0.01%	660
2016 Q2	$255K	Sell	2,184 -33,856	-94%	-$3.83M	0.01%	582
2016 Q1	$3.73M	Buy	36,040 +1,035	+3%	+$100K	0.11%	179
2015 Q4	$3.49M	Buy	+35,005	New	+$3.42M	0.09%	194
2013 Q4	–	Sell	-3,837	Closed	-$305K	–	481
2013 Q3	$305K	Sell	3,837 -117,621	-97%	-$9.26M	0.01%	375
2013 Q2	$8.84M	Buy	+121,458	New	+$9.08M	0.28%	104

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Chicago Equity Partners's ZBH Position: Q1 2020 in Review

Chicago Equity Partners reduced its Zimmer Biomet (ZBH) stake by 37% in Q1 2020, selling an estimated $847K and leaving 11,186 shares worth $1.1M. The position accounts for 0.11% of the portfolio, ranked #263.

Chicago Equity Partners first reported a position in ZBH in Q2 2013 and has held it in 12 quarters since. The position peaked at $8.84M in Q2 2013. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

Chicago Equity Partners held 11,186 shares of Zimmer Biomet worth $1.1M as of Q1 2020.
Chicago Equity Partners sold 6,458 Zimmer Biomet shares in Q1 2020, an estimated $847K.
Zimmer Biomet made up 0.11% of Chicago Equity Partners's portfolio in Q1 2020, its #263 holding.
Chicago Equity Partners first reported a position in Zimmer Biomet in Q2 2013 and has held it in 12 quarters since.
Chicago Equity Partners's Zimmer Biomet position peaked at $8.84M in Q2 2013.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.